VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF) , a clinical-stage biotech company dedicated to developing neurorestorative ...

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world® ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

The collapse of 23andMe is sparking important conversations — and unanswered questions — about genetic data privacy and ...

Campaigns, a public health initiative that promotes sustainable behavior change by dedicating every Monday to health, ...